Safety and Anti-Inflammatory Activity of Curcumin: A Component of Tumeric (Curcuma longa)

By N. Chainani-Wu. Journal of Alternative and Complementary Medicine, 2003

1,148 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment (2011, background): “up to 100 mg of curcumin), no toxicities or adverse effects have been reported or studied at the population level [23].”
Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications (2020, background): “According to Chainani-Wu (2003), who assessed curcumin’s safety and anti-inflammatory activity over the years 1966 to 2002, in a phase 1 human trial with 25 subjects using up to 8,000 mg of curcumin/day for 3 months, revealed no toxic effects.”
Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials (2008, neutral): “In India, where the average intake of turmeric can be as high as 2.0–2.5 g per day (corresponding to (cid:2) 60–100 mg of curcumin daily), no toxicities or adverse effects have been reported at the population level (33).”
Curcumin Extract for Prevention of Type 2 Diabetes (2012, neutral): “symptoms of patient complaints were recorded (20).”
Novel insights of dietary polyphenols and obesity. (2014, background): “The Asian Indian population has consumed curcumin at doses up to 100 mg/day for many years [131, 132].”